The use of glucagon-like peptide-1 receptor agonist (GLP-1 RA) is on the rise, as it has…
News & Perspectives
Phase 2 study reveals the promising effects of barzolvolimab in treating chronic spontaneous urticaria
A recent publication at the American Academy of Allergy, Asthma & Immunology revealed that patients suffering…
Lebrikizumab treatment demonstrates sustained improvement in atopic dermatitis patient outcomes
Atopic dermatitis (AD), a prevalent chronic inflammatory skin disorder affecting a substantial percentage of the global…
Bariatric surgery outperforms lifestyle changes in managing type 2 diabetes
Type 2 diabetes is a progressive multifactorial disease affecting approximately 10% of the world’s population. A…
Benralizumab emerges as a promising therapy for eosinophilic granulomatosis with polyangiitis
Benralizumab emerges as a promising therapy for eosinophilic granulomatosis with polyangiitis (EGPA), according to a group…
Study finds no significant link between preterm birth and autism in childhood
Autism Spectrum Disorder (ASD) is a prevalent developmental disorder affecting individuals worldwide. The World Health Organization…
RNA interference with zilebesiran is effective for mild to moderate hypertension
Hypertension is a significant global health concern, contributing to cardiovascular mortality and the progression of kidney…
Intravenous ertapenem therapy is effective and durable for recalcitrant hidradenitis suppurativa
In a recent study published in JAMA Dermatology, researchers revealed a breakthrough treatment for recalcitrant hidradenitis…
Gepotidacin excels in clinical trials, outperforming nitrofurantoin as a promising UTI treatment
A team of medical researchers has unveiled promising results from two Phase III non-inferiority clinical trials…
Research shows the efficacy of peptide receptor radionuclide therapy in treating metastatic insulinomas
A novel study published in The Journal of Nuclear Medicine has revealed the promising effectiveness of…